No Matches Found
No Matches Found
No Matches Found
Sarda Proteins Ltd
Sarda Proteins Ltd is Rated Strong Sell
Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.
Sarda Proteins Hits Intraday Low Amid Price Pressure and Market Headwinds
Sarda Proteins experienced a significant intraday decline, touching a low of Rs 74.11, reflecting a price pressure of 9.74% during today’s trading session. The stock’s performance contrasted sharply with broader market trends, highlighting immediate pressures within the edible oil sector.
Sarda Proteins Opens with Sharp Gap Down Amid Market Concerns
Sarda Proteins witnessed a significant gap down at the opening of trading today, with the stock price declining by 9.74% to open at Rs 74.11. This sharp drop reflects heightened market concerns within the edible oil sector, as the stock underperformed both its sector peers and the broader Sensex index.
Sarda Proteins Sees Revision in Market Assessment Amid Challenging Fundamentals
Sarda Proteins has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights the evolving challenges faced by the edible oil company, particularly in its financial performance and valuation metrics.
Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses
Sarda Proteins Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.58% and exhibiting a complete absence of buyers. This distress selling comes amid a series of consecutive losses, signalling heightened market caution towards the edible oil company.
Sarda Proteins Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
Sarda Proteins has captured market attention with an unusual trading pattern characterised by an upper circuit lock and exclusively buy orders in the queue. This rare phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, signalling a potential multi-day circuit scenario that investors are closely monitoring.
Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Losses
Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading floor. The edible oil company’s shares have recorded consecutive declines, reflecting distress selling signals that have intensified over recent months.
How has been the historical performance of Sarda Proteins?
Sarda Proteins has shown significant sales growth, with net sales rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, but faced challenges with increased expenditures, resulting in marginal operating profit and a decrease in profit after tax and EPS. Overall, while sales and total assets have grown, profitability remains a concern.
Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains
Sarda Proteins Ltd, a key player in the edible oil sector, is currently experiencing extreme selling pressure with only sell orders present in the market queue. Despite a recent streak of gains, the stock’s trading activity today signals distress selling, raising concerns about its near-term outlook.
Sarda Proteins Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust investor enthusiasm and raises the prospect of a sustained multi-day circuit scenario, setting it apart from sector peers and broader market trends.
Sarda Proteins Surges with Unprecedented Buying Interest, Hits Upper Circuit
Sarda Proteins has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The edible oil company’s stock has recorded a remarkable run of consecutive gains, signalling strong investor enthusiasm and the potential for a multi-day circuit scenario.
When is the next results date for Sarda Proteins?
The next results date for Sarda Proteins is 29 November 2025.
Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses
Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. This extreme selling activity signals distress among investors, as the stock continues to face consecutive losses despite recent short-term gains.
Sarda Proteins Sees Unprecedented Buying Interest, Edges Into Multi-Day Upper Circuit
Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust investor interest and the potential for a sustained multi-day circuit scenario, setting the edible oil sector abuzz.
Sarda Proteins Surges with Unprecedented Buying Interest, Edible Oil Sector Spotlight
Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a potential multi-day circuit scenario, setting the edible oil sector abuzz.
Sarda Proteins Hits Upper Circuit Amidst Unprecedented Buying Interest
Sarda Proteins has surged to hit the upper circuit limit today, driven by extraordinary buying interest with no sellers in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand for the stock within the edible oil sector.
Sarda Proteins Stock Falls to 52-Week Low of Rs.59.95 Amidst Weak Financials
Sarda Proteins has reached a new 52-week low of Rs.59.95, marking a significant decline in its stock price over the past year. The edible oil company’s shares have underperformed considerably compared to the broader market, reflecting ongoing financial difficulties and subdued operational performance.
Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Market Pressures
Sarda Proteins, a key player in the edible oil sector, touched a fresh 52-week low of Rs.59.95 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific factors.
Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Challenging Market Conditions
Sarda Proteins, a key player in the edible oil sector, touched a fresh 52-week low of Rs.59.95 today, marking a significant milestone in its recent price trajectory. This new low reflects ongoing pressures on the stock amid broader market movements and company-specific developments.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

